News >

Landmark Approvals Lead to Continual Progress in HER2+ Breast Cancer

Caroline Seymour
Published: Thursday, Apr 18, 2019

Cindy Osborne, MD

Cindy Osborne, MD

Since landmark approvals in HER2-positive breast cancer, the field continues to gain traction in terms of therapeutic developments, explained Cindy Osborne, MD, in a presentation during the 2019 OncLive® State of the Science Summit™ on Breast Cancer.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and MyelomaMay 30, 20192.0
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Publication Bottom Border
Border Publication
x